Profil bibliographique

Anushka Naidoo

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

48Publications signalées

1287Citations signalées

1Affiliations récentes

Institutions déclarées

Centre for the AIDS Programme of Research in South Africa

Domaines associés

Tuberculosis Research and EpidemiologyHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentPneumocystis jirovecii pneumonia detection and treatmentHIV Research and Treatment

Publications récentes

Accès ouvert 2025 articleOpenAlex

Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin

Emmanuella Chinonso Osuala, Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo, Kogieleum Naidoo et autres

0 citationsClinical Infectious Diseases

Accès ouvert 2025 articleOpenAlex

Fixed-dose combination bictegravir–emtricitabine–tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial

Anushka Naidoo, Kogieleum Naidoo, Marothi Letsoalo, Roeland E. Wasmann et autres

3 citationsThe Lancet HIV

Accès ouvert 2025 articleOpenAlex

A preliminary analysis of the impact of pharmacogenetic variation on bictegravir and dolutegravir concentrations in individuals with HIV and tuberculosis

Anushka Naidoo, Tomas Y Ferede, Kogieleum Naidoo, Roeland E. Wasmann et autres

0 citationsBritish Journal of Clinical Pharmacology

Accès ouvert 2025 articleOpenAlex

Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries

Sara Keller, Kogieleum Naidoo, Medhane Zekarias, Sussan Israel-Isah et autres

2 citationsPLoS ONE

Accès ouvert 2025 articleOpenAlex

Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study

Anushka Naidoo, Hylke Waalewijn, Kogieleum Naidoo, Marothi Letsoalo et autres

5 citationsThe Lancet HIV

Accès ouvert 2024 articleOpenAlex

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB

Kogieleum Naidoo, Anushka Naidoo, Alash’le Abimiku, Edine Tiemersma et autres

5 citationsBMJ Open

Accès ouvert 2023 articleOpenAlex

The utility of brain natriuretic peptide as a prognosticating marker in critical care patients

Anushka Naidoo, K De Vasconcellos

0 citationsSouthern African Journal of Critical Care

Accès ouvert 2023 articleOpenAlex

Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities

Theolan Adimulam, Thilona Arumugam, Anushka Naidoo, Kogieleum Naidoo et autres

6 citationsGenes

Accès ouvert 2023 articleOpenAlex

Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection

Emmanuella Chinonso Osuala, Anushka Naidoo, Kelly E. Dooley, Kogieleum Naidoo et autres

7 citationsExpert Review of Clinical Pharmacology

Accès ouvert 2023 articleOpenAlex

Dolutegravir once daily with rifampicin for HIV and tuberculosis

Anushka Naidoo, Kelly E. Dooley

4 citationsThe Lancet HIV

Accès ouvert 2023 articleOpenAlex

Clinical impact of plasma concentrations of first-line antituberculosis drugs

Rubeshan Perumal, Kogieleum Naidoo, Anushka Naidoo, Nesri Padayatchi

3 citationsSouth African Medical Journal

Accès ouvert 2022 articleOpenAlex

The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis

Rubeshan Perumal, Kogieleum Naidoo, Anushka Naidoo, Marothi P. Letsoalo et autres

8 citationsInternational Journal of Infectious Diseases

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.